title: Home treatment of hereditary angioedema with icatibant administered by health care professionals.
authors.forename: Henriette
authors.initials: H
authors.lastname: Farkas
authors.forename: Dorottya
authors.initials: D
authors.lastname: Csuka
authors.forename: Zsuzsanna
authors.initials: Z
authors.lastname: Zotter
authors.forename: Lilian
authors.initials: L
authors.lastname: Varga
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Böröcz
authors.forename: György
authors.initials: G
authors.lastname: Temesszentandrási
authors.forename: László
authors.initials: L
authors.lastname: Jakab
authors.forename: István
authors.initials: I
authors.lastname: Karádi
mesh_terms: D000328:Adult; D054179:Angioedemas, Hereditary / Q000188:drug therapy* / Q000235:genetics / Q000451:nursing* / Q000503:physiopathology; D001920:Bradykinin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D065094:Bradykinin B2 Receptor Antagonists; D050718:Complement C1 Inhibitor Protein / Q000235:genetics; D018450:Disease Progression; D005240:Feasibility Studies; D005260:Female; D006282:Health Personnel; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D011537:Pruritus / Q000209:etiology; D012008:Recurrence
chemical_list: D065094:Bradykinin B2 Receptor Antagonists; D050718:Complement C1 Inhibitor Protein; C065679:icatibant; D001920:Bradykinin